Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | NRAS |
Variant | A146T |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | NRAS A146T does not lie within any known functional domains of the Nras protein (UniProt.org). A146T results in increased Nras activity likely due to increased GDP/GTP exchange rate, activation of downstream signaling, and is identified as a secondary mutation conferring resistance to Braf and Mek inhibitors in culture (PMID: 22389471, PMID: 3043178). |
Associated Drug Resistance | Y |
Category Variants Paths |
NRAS mutant NRAS act mut NRAS A146T NRAS mutant NRAS exon4 NRAS A146X NRAS A146T |
Transcript | NM_002524.5 |
gDNA | chr1:g.114709583C>T |
cDNA | c.436G>A |
Protein | p.A146T |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002524.5 | chr1:g.114709583C>T | c.436G>A | p.A146T | RefSeq | GRCh38/hg38 |
NM_002524 | chr1:g.114709583C>T | c.436G>A | p.A146T | RefSeq | GRCh38/hg38 |
NM_002524.4 | chr1:g.114709583C>T | c.436G>A | p.A146T | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
NRAS A146T | acute lymphoblastic leukemia | sensitive | IHMT-RAF-128 | Preclinical - Cell culture | Actionable | In a preclinical study, IHMT-RAF-128 inhibited proliferation in an acute lymphoblastic leukemia cell line harboring NRAS A146T in culture (PMID: 37164118). | 37164118 |